What's New in Latent Tuberculosis Infection (LTBI): An Update for Minnesota Providers Webinar
|When:||Thursday, March 6, 2014
Noon - 1 p.m.
|Who:||Mayo Clinic Center for Tuberculosis
Dr. Timothy Aksamit, Mayo Clinic
Deb Sodt, RN, PHN, MPH, Program Manager, MDH TB Prevention and Control Program
Learning objectives include:
- Describe the use of shorter drug regimens for the treatment of LTBI.
- Describe the use of Interferon Gamma Release Assays (IGRAs) for TB testing.
- Describe the public health perspective on the advantages and limitations of using short LTBI regimens and IGRAs. CME and CNE will be offered.
Preregistration is required. To register, you will need to create an account here: Mayo Clinic Continuous Professional Development. Attn: Non-MDH link.
Questions about registration can be directed to the Mayo Clinic Center for Tuberculosis’s Education Director, Jennifer Curran (Phone: 507-266-0580).